Newsroom

Vizient, Inc. to Present at SMi’s Third Annual Biosimilars North America Conference

Category:

11/02/16

Dateline:

IRVING, Texas
"Vizient is strongly committed to the biosimilars market and works to educate hospital staff, physicians and pharmacists about biosimilars, their role in quality healthcare delivery and common misconceptions that could impact successful commercialization of these new pharmaceuticals."

IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced it will be presenting on the “Successful Commercialization of Biosimilars” to the hospital market segment at the Third Annual Biosimilars North America conference, November 17-18 in Iselin, New Jersey. Vizient’s L. Ross Day, R.Ph. D.P., director of pharmacy, Sourcing Operations will make the presentation.

The biosimilars market presents significant opportunities for pharmaceuticals and biotech companies. Over the last 12 months, market participants have witnessed revolutionary steps in the U.S. to facilitate commercialization. The conference will update attendees on the latest market developments and regulatory updates.

“Biologicals represent about 50% of any hospital’s pharmaceutical budget, so successful launches of biosimilars, and conversions to them by providers, can help lower the cost of care,” said Day. “Vizient is strongly committed to the biosimilars market and works to educate hospital staff, physicians and pharmacists about biosimilars, their role in quality healthcare delivery and common misconceptions that could impact successful commercialization of these new pharmaceuticals.”

What: “Successful Commercialization of Biosimilars”
When: Friday, November 18 at 11:00-11:40 a.m.
Who: L. Ross Day, R.Ph. D.P., director of pharmacy, Sourcing Operations, Vizient Inc.
Where: Renaissance Woodbridge Hotel, Iselin, New Jersey

About Vizient Inc.

Vizient, Inc., the largest member-driven health care performance improvement company in the country, provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents almost $100 billion in annual purchasing volume. The Vizient brand identity represents the integration of VHA Inc., University HealthSystem Consortium and Novation, which combined in 2015, as well as the recently acquired MedAssets’ Spend and Clinical Resource Management (SCM) segment, which includes Sg2. In 2016, Vizient received a World’s Most Ethical Company designation from the Ethisphere Institute. Vizient’s headquarters are in Irving, Texas, with locations in Chicago and other cities across the United States. Please visit www.vizientinc.com as well as our newsroom, blog, Twitter, LinkedIn and YouTube pages for more information about the company.

Contact:

Vizient, Inc.
Donna Ledbetter, 972-830-6321
donna.ledbetter@vizientinc.com

Related Materials